This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (9) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lazeron, R H. Articles by Barkhof, F Search for Related Content PubMed PubMed Citation Articles by Lazeron, R H. Articles by Barkhof, F Social Bookmarking                         What's this?

Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction

Department of Neurology, MS-Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands, rhc.lazeron{at}vumc.nl

L MJ de Sonneville

Department of Clinical Child and Adolescent Studies, Leiden University, Leiden, The Netherlands

P Scheltens

Department of Neurology, MS-Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands

C H Polman

Department of Neurology, MS-Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands

F Barkhof

Department of Radiology, MS-Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands

Introduction In this study, we investigated the influence of in vivo disease pathology (measured as magnetic resonance imaging (MRI) lesion load and brain volume reduction) on cognitive functioning, especially the speed of processing, in multiple sclerosis (MS) patients. Since MS is characterized by cognitive slowing rather than impaired accuracy, we used the Amsterdam Neuropsychological Tasks (ANT) program, a computerized test proven to be very sensitive to cognitive slowing in MS patients.

Methods Thirty-two patients performed the ANT and underwent MRI scanning. Using the ANT computerized tests, we investigated focused, divided, sustained attention, executive function and psychomotor function, and examined associations of speed, speed fluctuation and accuracy of performance of these tests with MRI lesion load and brain volume parameters.

Results A decrease in the speed of processing and response speed stability, and a decrease in psychomotor accuracy and stability were clearly associated with less brain volume, and with higher lesion loads, in particular at frontal and occipital areas. Correlations with brain volume reduction were found for all domains, except for visuo-spatial processing. In particular, speed and speed fluctuation scores correlated with brain volume reduction, while accuracy of performance, in general, did not correlate. Only some test speed scores and speed fluctuation scores correlated with lesion load measurements.

Conclusion This study shows that, in MS patients, accuracy of processing is not compromised unless high working memory demands are involved. Problems in neurocognitive functioning in MS are mainly modulated by speed and stability of speed processing, in particular when attention-demanding controlled information processing is required. Abnormalities in these domains are most strongly associated with brain volume loss, confirming that pathology beyond focal lesions is important in MS.

Key Words: ANT • magnetic resonance • multiple sclerosis • neuropsychology

Multiple Sclerosis, Vol. 12, No. 6, 760-768 (2006)
DOI: 10.1177/1352458506070924


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M Ukkonen, T Vahvelainen, P Hamalainen, P Dastidar, and I Elovaara Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study Multiple Sclerosis, September 1, 2009; 15(9): 1055 - 1061. [Abstract] [PDF]

				F Patti, M. Amato, M Trojano, S Bastianello, M. Tola, B Goretti, L Caniatti, E Di Monte, P Ferrazza, V Brescia Morra, et al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study Multiple Sclerosis, July 1, 2009; 15(7): 779 - 788. [Abstract] [PDF]

				F. Patti, M. Pia Amato, S. Bastianello, L. Caniatti, E. Di Monte, F. Lijoi, B. Goretti, S. Messina, O. Picconi, M. R. Tola, et al. Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing--remitting multiple sclerosis: 2-year results from the COGIMUS study Therapeutic Advances in Neurological Disorders, March 1, 2009; 2(2): 67 - 77. [Abstract] [PDF]

				S. A. Gauthier, A. M. Berger, Z. Liptak, Y. Duan, S. Egorova, G. J. Buckle, B. I. Glanz, S. J. Khoury, R. Bakshi, H. L. Weiner, et al. Rate of Brain Atrophy in Benign vs Early Multiple Sclerosis Arch Neurol, February 1, 2009; 66(2): 234 - 237. [Abstract] [Full Text] [PDF]